ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 189 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $40,000 | -7.0% | 857 | -6.2% | 0.00% | – |
Q3 2019 | $43,000 | -17.3% | 914 | +3.0% | 0.00% | – |
Q2 2019 | $52,000 | +67.7% | 887 | +27.8% | 0.00% | – |
Q1 2019 | $31,000 | +6.9% | 694 | -3.7% | 0.00% | – |
Q4 2018 | $29,000 | -27.5% | 721 | -18.0% | 0.00% | – |
Q3 2018 | $40,000 | +11.1% | 879 | -2.2% | 0.00% | – |
Q2 2018 | $36,000 | 0.0% | 899 | 0.0% | 0.00% | – |
Q1 2018 | $36,000 | +71.4% | 899 | +45.2% | 0.00% | – |
Q4 2017 | $21,000 | +31.2% | 619 | 0.0% | 0.00% | – |
Q3 2017 | $16,000 | +77.8% | 619 | +19.3% | 0.00% | – |
Q2 2017 | $9,000 | – | 519 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |